Display Settings:

Format

Send to:

Choose Destination
Clin Pharmacol Ther. 2010 Jun;87(6):635-8. doi: 10.1038/clpt.2010.4.

Dealing with the evidence dilemma in genomics and personalized medicine.

Author information

  • National Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. muk1@cdc.gov

Abstract

In this commentary, I discuss how the promise of genomics and personalized medicine (GPM) is currently not matched by the evidence that supports its use in clinical practice. The mismatch between expectations and reality can be addressed by placing greater emphasis on multidisciplinary translation research and by stakeholder-driven collaboration that uses such research to address various and occasionally competing factors affecting the integration of genomic discoveries into clinical practice.

PMID:
20485318
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk